General Information
Version
6.2
Revision date
2025-05-17
Product name
Regadenoson
CAS No.
313348-27-5
Emergency telephone
+44 (0)870 8200418
Icons in SDS
Company Information
company name
Merck Life Science UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
Section 2
SECTION 2: Hazards identification
Regulation, UK SI 2019/720, and UK SI 2020/1567 Classification of the substance or mixture
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher. Caution: Physiologically highly active, therapeutically usable substance. The substance must be handled with the care required for hazardous materials.
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 as amended by GB-CLP Regulation, UK SI 2019/720, and UK SI 2020/1567 Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.
